Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN Exclusives

Back to Item »

Biopharma IPO Forecast for 2012 Expected to Remain Chilly

In a survey of venture capitalists and CEOs, 58% predict reduced investment.

Forward this item to a colleague:


(Separate multiple addresses by commas)